MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effects of balance training in patients with cervical dystonia

    J. Richter, C. Weise, A. Villringer, P. Ragert, D. Weise (Leipzig, Germany)

    Objective: To investigate if patients with cervical dystonia (CD) show more subtle deficits in static and dynamic balance as well as learning a whole body…
  • 2018 International Congress

    Start React Paradigm In Patients With Cervical Dystonia

    R. Singh, S. Choudhury, A. Roy, K. Chatterjee, M. Mondal, M. Baker, S. Baker, H. Kumar (Kolkata, India)

    Objective: Compare StartReact paradigm in cervical dystonia (CD) patients compared to matched healthy participants. Background: The voluntary response to vestibular stimulation is enhanced in CD…
  • 2018 International Congress

    Prevalence of focal task specific lower extremity dystonia symptoms in runners

    R. Thompson, A. Hellman, D. Torres-Russotto (Lebanon, NH, USA)

    Objective: The objective of this study was to survey a group of self-identified runners to determine the prevalence of symptoms suspected to be lower extremity…
  • 2018 International Congress

    Paroxysmal kinesigenic dyskinesia successfully treated with lamotrigine –description of 2 cases

    E. Papuć, K. Rejdak (Lublin, Poland)

    Objective: To present 2 cases of our patients with paroxysmal kinesigenic dyskinesias (PKD) , who had intolerance or ineffectiveness of carbamazepine (CBZ), and presented good…
  • 2018 International Congress

    Mortality from Parkinson’s disease in China: Findings from a Ten-year follow up study in Shanghai

    G. Wang, G. Xu, YQ. Zhang, SD. Chen (Shanghai, China)

    Objective: To examine the outcome, including overall and cause-specific mortality, of PD patients subsequent to 10 years of surveillance in Shanghai, China. This is an…
  • 2018 International Congress

    Cerebrospinal fluid proteomics reveals alterations of the renin-angiotensin system in Huntington’s disease

    V. Niemelä, J. Sundblom, A.M. Landtblom, D. Nyholm (Uppsala, Sweden)

    Objective: To identify new biomarkers of disease stage in HD. Background: Proteomic approaches for CSF studies in Huntington’s disease (HD) have so far yielded limited…
  • 2018 International Congress

    Neurofilament light protein: An emerging clinical and translational biofluid biomarker for Huntington’s disease

    L. Byrne, F. Rodrigues, E. Johnson, S. Gregory, R. Soylu Kucharz, M. Björkqvist, A. Heslegrave, K. Blennow, A. Durr, B. Leavitt, R. Roos, S. Tabrizi, H. Zetterberg, D. Langbehn, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To investigate whether neurofilament light protein (NfL) a potential prognostic marker of neurodegeneration with Huntington’s disease. Background: NfL, a component of the axonal cytoskeleton,…
  • 2018 International Congress

    Baseline predictors of clinical and imaging progression in Parkinson’s disease: Results from the PPMI study

    L. Chahine, A. Siderowf, C. Caspell-Garcia, J. Barnes, N. Seedorff, C. Coffey, D. Galasko, B. Mollenhauer, V. Arnedo, N. Daegele, M. Frasier, C. Tanner, K. Kieburtz, K. Marek (Pittsburgh, PA, USA)

    Objective: To identify clinical, imaging, and biochemical measures, obtained early in the disease course that predict clinical and dopamine transporter (DAT) imaging progression in PD.…
  • 2018 International Congress

    Pronounced synucleinopathy and nigrostriatal degeneration result in forelimb use deficits in the rat preformed alpha-synuclein fibril model

    J. Patterson, M. Duffy, T. Collier, K. Luk, C. Kemp, J. Howe, P. Patel, A. Stoll, K. Miller, N. Kanaan, K. Paumier, C. Sortwell (Grand Rapids, MI, USA)

    Objective: Generation of a synucleinopathy model in rats using injections of α-synuclein preformed fibrils (α-syn PFFs) resulting in robust and widespread α-syn pathology and at…
  • 2018 International Congress

    Speech and Language Therapy (SLT) for Inpatients with Parkinson’s (IwP) in a Large District General Hospital

    J. Martin, A. Chatterjee (Reading, United Kingdom)

    Objective: To improve access to SLT for the MDT and IwP at the Royal Berkshire Hospital. Background: A successful bid in Jan 2017 for a…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley